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Abstract
Background Providers and healthcare organizations have
begun recognizing the importance of patient empowerment
as a driver of patient-centered care. Unfortunately, most
studies have investigated empowerment with single dis-
eases. Identifying factors of empowerment across condi-
tions and populations would enable a greater understanding
of this construct.
Objective The purpose of this study was to understand
empowerment in relation to health information-seeking,
interactions with providers and peers, and healthcare access
in chronic disease patients. This study also sought to
identify key empowerment factors and their association
with patient characteristics.
Methods Participants were recruited through Patient-
sLikeMe, an online research platform where patients share
their personal and medical history data. Patients completed
an online survey that assessed self-reported health behavior
(e.g. knowledge-seeking, experiences with healthcare pro-
viders, and peer interactions) and healthcare access. An
exploratory factor analysis identified key empowerment
domains. Domain level sum scores and sum of all domains
(total score) were compared across patient characteristics
and diseases.
Results Overall, 3988 participants were included in the
study, with the majority actively involved in their
healthcare, but many cited difficulties with matching their
treatment goals with those of their physician (34 %) and
spending sufficient time with the physician (36 %). Factor
analysis identified two domains—Positive Patient–Provi-
der Interaction, and Knowledge and Personal Control—
that explained [60 % of the overall variance in the
observed variables. Mean total empowerment scores for
patients with a primary complaint of Parkinson’s disease
(61.8) and multiple sclerosis (60.3) were significantly
greater than fibromyalgia (55.3) and chronic fatigue syn-
drome (54.8). Patients who were older, male, more edu-
cated, and insured also reported significantly greater
levels of empowerment.
Conclusions The two domains of empowerment identi-
fied in this study are consistent with previous studies, but
the differences in empowerment levels across diseases
suggest a need for further studies on disease-related
attributes of empowerment. Future research should
examine the pathways for empowerment, as well as the
relationship between empowerment domains and clinical
outcomes.
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Key Points for Decision Makers
Clinicians: Greater attention needs to be paid to
helping clinicians provide sufficient time to develop
mutually acceptable treatment goals with patients, as
well as attend to informational needs in difficult-to-
treat conditions.
Patients: Educating patients about the importance of
seeking support to improve knowledge and a sense
of control may enhance empowerment, particularly
in difficult-to-manage chronic conditions.
Researchers: Interpersonal and intrapersonal factors
in empowerment have been identified but further
research is needed to examine causal relationships
among key constructs.
1 Background
Patients with chronic diseases are faced with a broad array
of treatment options that require healthcare knowledge, the
ability to navigate services and providers, and a proactive
approach to self-care [1]. These challenges are especially
magnified in patients who have differential access to care
based on healthcare insurance, education, and income [2].
To address these needs, providers and healthcare organi-
zations have begun recognizing the importance of involv-
ing patients more proactively in their treatment. The
Institute of Medicine highlighted the importance of the
patient as ‘‘the source of control’’ in medical care [3]. The
emergence of the Patient-Centered Outcomes Research
Institute (PCORI) [4] and Food and Drug Administration
(FDA) Patient-Focused Drug Development Initiative [5]
have led to important patient-centered initiatives. The
PCORI has involved underserved patients in the develop-
ment and implementation of comparative effectiveness
studies. As a means of informing regulatory decisions, the
FDA is conducting meetings to capture the ‘patient voice’
in conditions such as fibromyalgia and lung cancer. The
importance of engaging patients in their care has been
magnified by findings suggesting that patients with the
skills and confidence to manage their health achieve better
health outcomes and help drive lower costs [1]. To advance
these aims, the National Quality Strategy has emphasized
that patients and their families engage as partners in their
care [6].
These trends have helped give rise to an emphasis on
patient empowerment as a driver of patient-centered care
[7]. Recent reviews have found that empowerment is not
disease-specific and can be regarded as a psychosocial
skill, a result of experiential learning, and a determinant
of a reciprocal relationship with provider(s) [8]. Johnson
[9] and Small et al. [10] have proposed models of
empowerment that suggest the primacy of interpersonal
and intrapersonal factors. Johnson’s Model of Health
Care Empowerment suggests an interplay of personal
resources (e.g. problem solving, communication, health-
care access), cultural/social/environmental factors (e.g.
perceived norms, stigma, trauma), and intrapersonal
factors (e.g. depression, hope), which ultimately influ-
ence healthcare empowerment (e.g. engagement, collab-
oration) [9]. Small et al. [10] conducted a postal
validation study of an empowerment measure with an
elderly group of women with chronic diseases recruited
from general practices. A qualitative study identified five
dimensions (identity, knowledge and understanding, per-
sonal control, personal decision making, and enabling
other patients) but these were not confirmed in a survey
conducted to validate the new novel empowerment
measure. A three-factor solution included ‘positive atti-
tude and sense of control’ and ‘knowledge and confi-
dence in decision making’, but the third factor was
comprised of a mixture of items and could not be clearly
identified. The authors concluded that the lack of clarity
in these results required further testing and that scoring
be restricted to a total score.
Identifying factors of patient empowerment is particu-
larly important for achieving better outcomes with patients
who have chronic conditions [10]. Higher levels of
empowerment are associated with fewer symptoms [11].
Active participation in healthcare is associated with greater
perceived confidence in treatment adherence and with self-
reports of recent medication adherence [12]. Another line
of research has evaluated the efficacy of face-to-face,
group, or Internet-based educational programs to promote
patient empowerment in decision making or provider
interactions [13]. Unfortunately, most studies have inves-
tigated empowerment as a construct with single diseases
[12, 14]. It would be useful to identify factors of empow-
erment broadly across conditions and populations.
The purpose of this study was to understand empower-
ment in terms of how chronic-disease patients in an online
community engage in health information seeking, interac-
tions with providers and peers, and healthcare access. In
addition, this study sought to identify key factors in
empowerment and their association with patient charac-
teristics. Ultimately, such analyses may inform actionable
steps that both patients and providers can take in order to
encourage and improve patient empowerment.
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2 Methods
2.1 Participants and Procedures
Patients were recruited through PatientsLikeMe (PLM;
http://www.patientslikeme.com), an online research plat-
form that allows patients to share personal health infor-
mation through structured data collection [15]. At present,
PLM has over 430,000 members representing over 2600
conditions. PLM members self-report demographic, diag-
nosis, medical history, treatment, and symptom data. Due
to the availability of a large, multiple-disease patient cohort
in an online research network, PLM is able to quickly and
efficiently recruit participants in surveys. In recent years,
the use of online surveys has multiplied due to the reduced
burden on participants, cost effectiveness, and automation
of data collection and tracking when compared with mail
surveys [16]. However, because of self-selection in online
populations, the sample constitution may differ from rep-
resentative population-based samples [17]. The advantages
of online survey administration on PLM have been docu-
mented in previous studies [18].
The inclusion criteria were registration on the PLM
website, one or more chronic health condition(s) on the
PLM profile, and age C18 years. In the survey sample, we
included conditions that were reported by more than five
patients. Members were not remunerated for their partici-
pation. Invitations were sent via electronic message to an
unrestricted convenience sample of PLM members. Par-
ticipation in the survey was voluntary, and the nature and
potential risks of the study were explained. Informed
consent was obtained electronically before commencing
the survey. The research protocol was approved by the
New England Institutional Review Board (NEIRB) on 4
November 2014, and the online survey was administered to




Variables included in the analyses were age, gender, race,
residence, health insurance, education, primary condition
(i.e. a member’s chief complaint) and other comorbidities,
which patients report in their PLM profile.
2.2.2 Empowerment Survey
The creation of the survey began with a review of pub-
lished studies to identify concepts and domains of
empowerment. A detailed review of the articles identified a
theoretical framework of patient empowerment in chronic
disease that helped inform development of survey items
[10]. A list of questions was generated from the concepts
identified in the studies and was subjected to an iterative
process of development and selection by the authors. Skip-
logic (also known as conditional branching), an interactive
feature that allows respondents to skip questions not
applicable to them based on prior responses, was then
embedded within the survey to improve usability. Devel-
opment and pretesting (comprehensibility and functionality
of the electronic questionnaire) were carried out iteratively
by the team of research investigators. The survey was then
reviewed for editorial and technical suggestions by patient
community moderators at PLM. This stepwise process
fulfilled the criteria outlined in the Checklist for Reporting
Results of Internet E-Surveys (CHERRIES) [17]. For
supplemental analyses, survey data were combined with
profile data from PLM member accounts.
The final survey included 47 questions covering demo-
graphic items not included in the PLM profile (e.g.
employment and marital status), self-reported health
behavior (knowledge seeking, patient–provider interac-
tions, and peer interactions), and healthcare access.
Response options varied by the type of questions, and
ranged from numerical, categorical (multiple choice—
mutually exclusive or inclusive and exhaustive), ordinal
(Likert scale), to open-ended comments. Response options
for empowerment domain items were set to a 5-point Likert
rating scale (ordinal scale ranging from least to most
desirable in order to have sufficient variability to uncover
latent structure of factor models). Survey responses were
collected using the online research survey tool developed
by PLM and stored in a secure database. A copy of the
survey, as fielded to participants, has been added as Online
Resource 1.
2.3 Data Analysis
Analyses were conducted in patients who completed the
entire survey. Individuals who terminated the survey early
were excluded and no imputation was performed for
missing data. Duplicate entries were also removed from
analyses. Data analyses were performed in SAS version 9.4
(SAS Institute Inc., Cary, NC, USA), and the level of
significance was set at a = 0.05. Given the large sampling
frame, a priori power estimation was not performed. Data
analyses were conducted using the following steps:
2.3.1 Descriptive Analysis
Descriptive statistics were computed for demographic
variables and survey items, and were presented as mean
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[standard deviation (SD)] for continuous variables (me-
dian, interquartile range for non-normally distributed
variables) and frequency (%) for categorical variables.
Differences in demographic distribution between com-
pleters and non-completers were tested using the t test for
continuous variables (Wilcoxon test for non-normal data)
and the Chi-square test for categorical variables.
2.3.2 Exploratory Factor Analysis
2.3.2.1 Factor Solution Summary statistics of the
empowerment questions at the item level were computed as
means, SDs and percentages for all Likert scale rating
items (range 1–5). To explore dimensionality of the ques-
tions and the number of distinct common factors measuring
the underlying construct of empowerment, exploratory
factor analysis (EFA) was performed for 26 candidate
items. Optimum factor solution was identified by examin-
ing (i) eigenvalues ([1); (ii) scree plot; and (iii) factor
loadings (C0.4) and cross-loadings. Principal axis factoring
followed by promax rotation was run on the final factor
solution following item reduction (i.e. removing items with
factor loading\0.4). Finally, Cronbach’s a was computed
for each factor to measure the scale reliability (internal
consistency), and item-to-total correlations and item-level
discriminant validity of each item in relation to the
underlying factor were computed. The sum score of all
items in the common factor(s) identified by EFA were used
as composite measures for each domain. While explora-
tory, the composite scale metric has several advantages.
Mean scores may be useful for comparisons across factors
when there are differing numbers of items per factor.
Summed factor scores preserve the variation in the original
data and is a common approach in exploratory research
studies [18]. The domains identified from the final EFA
solution were then assigned nomenclature that explained
the items contained in the domain. For subsequent analy-
ses, domain level scores were used as measures of domains
of empowerment, and the sum of all retained items were
used as the total empowerment score. Furthermore, items
that were retained from the EFA were examined by tabu-
lating the percentage of positive responses (rating of 4 or 5
on the 5-point Likert items) across the most prevalent
primary conditions.
2.3.2.2 Subgroup Analysis using Factor Scores Mean
factor scores were examined across different strata of the
study population. The stratifying variables were age, gen-
der (male vs. female), education (high school or less vs.
attended college vs. advanced degree), health insurance
status (yes vs. no), work status (able to work vs. medically
disabled to work), and primary condition. Ninety-five
percent confidence intervals (CIs) were computed around
the means where appropriate. For comparing scores across
primary conditions with the design-based weighted mean
of the overall sample, the analysis of means (ANOM)
procedure was selected. ANOM is a multiple comparison
procedure that constructs simultaneous critical values and
CIs to contrast subgroups with the overall weighted mean,
while controlling the type I error rate. Decision limits were
plotted to statistically and visually test the hypothesis of
differences in condition-specific means with the overall
weighted mean after Nelson–Hsu multiplicity adjustment.
3 Results
3.1 Descriptive Analysis Results
3.1.1 Survey Participation
PLM members (n = 294,795) were invited to participate in
the survey. Of these members, 21,923 viewed the invitation
and 6872 patients electronically consented to participate in
the survey; 15,501 did not respond or opted out. Among
consented patients, 1535 were excluded box (dupli-
cates = 3, asked to be removed after consent n = 1, and
did not meet eligibility criteria = 1531). Of the remaining
5337 participants, 3988 completed the survey; 1349
abandoned the survey after starting.
3.1.2 Response Rate
The view rate (views/invites), participation rate (participants/
views) and completion rate (completers/participants) were 7,
24, and 75 %, respectively. The completion rate was higher
(75 vs. 60 %) than Internet surveys of similar length [19].
Figure 1 represents the flow of participants through the
study. Eligible participants who completed the survey
(n = 3988) were included in the final analyses sample.
Using available data (all participants may not have
complete demographic data), comparisons of completers
and non-completers indicated that the former were slightly
older than the latter (mean 52.5 vs. 51.2 years, t = 3.2,
p = 0.001) and completers reported more chronic condi-
tions on their PLM profile (median 2 vs. 1, z = 10.4,
p\ 0.0001). Of note, completers were more likely to be
White, more educated, medically unable to work, have
health insurance, and reside in the US (see Table 1).
3.1.3 Demographic and Disease Characteristics
The mean age of the study sample at the time of the survey
was 52.5 years (SD 12 years), with a median of two self-
reported conditions listed on their PLM profile (interquar-
tile range 1–4). The majority of participants were females
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(72 %, n = 2883), White (90 %, n = 3594), and attended
college (82 %, n = 3279). Most participants had health
insurance (90 %, n = 3602) but more than one-third of
patients (37 %, n = 1464) were medically unable to work.
The most prevalent primary conditions were fibromyalgia
(20 %, n = 814), multiple sclerosis (19 %, n = 766), and
Parkinson’s Disease (8 %, n = 319). More than three-
quarters (77 %, n = 3094) of patients were affected ‘often’
to ‘always’ in their activities of daily living due to their
condition. Participants reported high levels of prediagnosis
healthcare involvement, with 87 % (n = 3504) citing that
it was somewhat or very important to them to be involved
in making decisions about their health prior to diagnosis
(see Table 1 for more information).
Compared with the US Department of Health and
Human Services statistics on chronic disease populations,
our study sample underrepresents the most prevalent
chronic conditions (e.g. cardiometabolic and respiratory
diseases), ethnic minorities and older patients, and over-
represents debilitating neurological and movement disor-
ders (fibromyalgia, multiple sclerosis, Parkinson’s disease),
females, and more educated and insured participants [20].
The proportion of females in this sample may be partially
explained by the gender distribution of fibromyalgia
(80–90 % females) [21] and multiple sclerosis (as high as
3:1 to 4:1 females) [22]. Finally, multiple sclerosis and
Parkinson’s disease are less common in minority popula-
tions [22, 23].
3.1.4 Health Information Seeking and Interactions
Our study sample generally reported positive indicators of
health education, as well as positive interactions with pro-
viders and peers. Knowledge-seeking behavior was repor-
ted to be high, with resources such as health websites
(WebMD, MayoClinic, etc.), patientslikeme.com, books,
magazines, and journals cited by 87 % (n = 3489), 60 %
(n = 2411), 43 % (n = 1734), 40 % (n = 1598), and 36 %
(n = 1431) of patients, respectively, as sources they use to
learn about their condition. Patients sought educational
resources for a variety of reasons, including (in descending
order) learning about treatment options (83 %, n = 3315),
course and progression of disease (76 %, n = 3050), signs
and symptoms (68 %, n = 2720), cause of condition (51 %,
n = 2029), initial diagnosis (50 %, n = 2001), and health
monitoring (48 %, n = 1926). The majority of patients
assessed health information verbally from providers (59 %,
n = 2359), and many of them also accessed paper copies
(43 %, n = 1714) and patient portals (43 %, n = 1711).
3.1.5 Interactions with Health Providers and Peers
Most patients reported positive impressions of their health
interactions with their providers and peers. Sixty-four
percent (n = 2633) agreed that they were content with
access to healthcare services and approximately three-
quarters (73 %, n = 2883) were satisfied with continued
care from their provider and healthcare institution (73 %,
n = 2879). Seventy-seven percent (n = 3061) were satis-
fied with their primary provider relationship, the majority
of patients (79 %, n = 3147) agreed that they have a say in
treatment decision making, and 73 % (n = 2888) reported
satisfaction with the continued care from their provider.
Despite these positive reactions, a sizable minority of
patients did not feel that their treatment goals matched their
providers’ plan (34 %, n = 1251) or that they spent an
adequate amount of time with their main provider during
visits (36 %, n = 1426). In addition, the percentage of
positive responses (4 or 5 on the 5-point Likert scale)
across primary conditions was lowest for the following two















(Did not meet eligibility criteria n=1,531;
Duplicates n=3;
Fig. 1 Study participation process. Overall, 21,923 participants
viewed the invitation, of whom 6872 patients electronically consented
to participate in the survey; 15,051 did not respond or opted out.
Among consented patients, 1535 were excluded box (duplicates = 3,
asked to be removed after consent n = 1, did not meet the eligibility
criteria = 1531). Of the remaining 5337 participants, 3988 completed
the survey; 1349 abandoned the survey after starting. The view rate
(views/invites), participation rate (participants/views), and comple-
tion rate (completers/participants) were 7, 24, and 75 %, respectively
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Age [years; mean ± SD] 52.5 ± 12.2 51.2 ± 12.8 3.2 0.001
Number of self-reported conditions [median (IQR)] 2 (1–4) 1 (1–2) 10.4 \0.0001
Gender [% (n)] 0.1 0.706
Female 72 (2883) 65 (882)
Male 28 (1094) 26 (344)
Unreported \1 (11) 9 (123)
Race [% (n)] 9.2 0.002
White 90 (3594) 79 (1071)
Non-White 8 (321) 10 (133)
Unreported 2 (73) 11 (145)
Education [% (n)] 6.8 0.033
Less than college 16 (638) 16 (212)
Attended college 62 (2462) 52 (701)
Advanced degree 20 (817) 15 (203)
Unreported 2 (71) 17 (233)
Health Insurance [% (n)] 12.7 \0.001
Yes 90 (3602) 72 (974)
No 7 (267) 8 (110)
Unreported 3 (119) 20 (265)
Work status [% (n)] 13.1 \0.001
Medically unable to work 37 (1464) 26 (356)
Able to work 61 (2423) 57 (765)
Unreported 2 (101) 17 (228)
Region [% (n)] 13.1 0.004
US 69 (2744) 60 (810)
UK 13 (534) 14 (193)
Canada 8 (323) 6 (79)
Other 9 (379) 11 (145)
Unreported \1 (8) 9 (122)
Primary condition [% (n)] 108.7 0.018
Fibromyalgia 20 (814) 22 (301)
Multiple sclerosis 19 (766) 16 (213)
Parkinson’s disease 8 (319) 7 (89)
Type 2 diabetes mellitus 5 (193) 6 (76)
Epilepsy 4 (165) 3 (37)
Amyotrophic lateral sclerosis 3 (110) 4 (48)
Rheumatoid arthritis 3 (123) 2 (33)
Systemic lupus erythematosus 3 (100) 2 (33)
Major depressive disorder 2 (95) 2 (33)
Idiopathic pulmonary fibrosis 2 (90) 2 (27)
Myalgic encephalomyelitis/chronic fatigue syndrome 2 (76) 3 (45)
Migraine 2 (64) 2 (25)
Bipolar disorder type 2 1 (55) 1 (17)
Other 24 (979) 29 (398)
Interference in activities of daily living (often–always) [% (n)] 78 (3094) –
Prediagnosis healthcare involvement (important–very important)
[% (n)]
87 (3504) –
SD standard deviation, IQR interquartile range
a Test statistics for the difference between completers and non-completers were computed using available profile data only (excluding unreported). The
test statistic is t test for age, Wilcoxon two-sample z test for condition count (non-normal distribution), and Chi-square test for categorical data.
Multiplicity adjustments were not performed
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healthcare provider monitors your ongoing care (a great
deal or quite a bit; 55 % across all conditions); and (2) I
have as much support as I need from friends to help care
for and manage my condition (strongly agree or agree;
47 % across all conditions).
Peer interactions were also noted among patients, with
74 % (n = 2943) citing enabling other patients (‘‘I have
shared my experience of managing my condition with other
people’’) and 69 % (n = 2739) learning from others (‘‘Do
you learn from the experiences of other members that are
part of online communities like PatientsLikeMe?’’).
3.2 Exploratory Factor Analysis
We assessed 26 survey items (see Online Resource 2) using
EFA to examine common factors that measure the underly-
ing construct of empowerment. Due to the non-normal dis-
tribution of data, we applied the principal axis factoring
method, which is robust for non-normal data distributions.
Sampling adequacy for EFA measured by Kaiser–Meyer–
Olkin (KMO) revealed adequate sample size (KMO = 0.9).
The optimum EFA solution had two factors with eigenvalues
of 5.7 and 1.3 for the first and second factors, respectively,
accounting for[60 % of the overall variance in the observed
variables. Sixteen (n = 16) items loaded[0.4 on one of the
two factors, with a few items loading on more than one factor
(cross-loading) (Table 2; see Appendix 2 for all 26 items).
Discriminant validity of the 16 items assessed by corrected
item-to-total correlation (correlations between items and
total domain score with the item excluded in the domain
total) [24] showed one item on the second factor had poor
discriminant validity (\0.4) and was removed. The final
factor solution contained eight items on the first factor and
seven on the second factor. After reviewing the items con-
tained within each factor (domain), the factors were named
according to what the common theme of items within each
factor best represented, i.e. ‘Positive Patient–Provider
Interaction’ and ‘Knowledge and Personal Control’. Internal
consistency testing of the factors demonstrated accept-
able Cronbach’s a for each domain (a[ 0.79). The factor
scores were used as composite measures of each domain and
the sum of both factor scores was used as the ‘Total
Empowerment Score’. A higher score indicates greater
empowerment for Positive Patient–Provider Interaction
(minimum 8, maximum 40), Knowledge and Personal
Control (minimum 7, maximum 35), and Total Empower-
ment Score (minimum 15, maximum 75) domains.
3.2.1 Patient Empowerment and Patient Characteristics
Positive Patient–Provider Interaction scores varied by
patient characteristics, including primary condition, age,
gender, insurance status, and education. Mean scores were
higher in males (males 32.5 vs. females 31.6), more edu-
cated (advanced education 32.7 vs. college 31.9 vs. high
school or less 30.8), and older (with the exception of age
category [75 years) patients, and lower in uninsured
patients (uninsured 28.2 vs. insured 32.1) (Table 3). No
significant difference was noted in the scores of patients by
work status (medically unable to work vs. able to work).
Furthermore, patients with myalgic encephalomyelitis/
chronic fatigue syndrome (28.6), systemic lupus erythe-
matosus (29.4), and fibromyalgia (29.7) reported signifi-
cantly lower scores compared with the overall weighted
mean (Fig. 2). Patients with neurological disorders,
including Parkinson’s disease (33.5) and multiple sclerosis
(33.1), reported significantly higher scores compared with
the overall weighted mean.
There were two particular items in this scale that
revealed specific differences by conditions. In patients with
amyotrophic lateral sclerosis, 86 % responded that they
strongly agree or agree (compared with 73 % across all
diseases) to the survey item: ‘‘I am well-informed about the
available treatment options for my primary health condi-
tion’’. For the same item, patients with Parkinson’s disease
and multiple sclerosis also had a high percentage of
agreement (84 and 85 %, respectively); however, the per-
centage agreement for patients with fibromyalgia (58 %)
and chronic fatigue syndrome (59 %) was less for the same
survey item (see Online Resource 3). Compared with the
overall sample, a smaller percentage of fibromyalgia
(63 %) and chronic fatigue syndrome (64 %) respondents
positively endorsed ‘‘How much of the health information
you received from healthcare providers during your visits
was clear and easy to understand’’.
Knowledge and Personal Control scores were higher in
males (males 27.8 vs. females 26.4), more educated (ad-
vanced education 27.7 vs. college 26.6 vs. high school or
less 26.2), and older patients, and lower in those uninsured
(uninsured 24.9 vs. insured 26.9) and patients who were
medically unable to work (medically unable to work 26.2
vs. able to work 27.1) (Table 3). Patients with major
depressive disorder (24.5), myalgic encephalomyelitis/
chronic fatigue syndrome (24.7), and fibromyalgia (24.8)
reported significantly lower scores compared with the
weighted sample mean (Fig. 2), while patients with neu-
rological disorders, including amyotrophic lateral sclerosis
(28.4), Parkinson’s disease (28.0), and multiple sclerosis
(27.8) reported higher scores than overall weighted mean.
As expected, Total Empowerment scores also differed by
sociodemographic and primary conditions (Table 3).
3.2.2 Patient Empowerment and Healthcare Access
Satisfaction with healthcare access (sum score of a nine-
item unidimensional construct) was also strongly
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correlated with empowerment scores (Total Empowerment
Scorer = 0.7, p\ 0.0001; Positive Patient–Provider
Interaction, r = 0.7, p\ 0.0001; Knowledge and Personal
Control, r = 0.6, p\ 0.0001; not shown in the tables).
4 Discussion
The goal of the present study was to gain an understanding
of empowerment in terms of how chronic disease patients
participating in an online community engage in health
information seeking, interact with providers and peers, and
access healthcare. The analysis of the sample as a whole
revealed a fairly engaged and empowered group, but many
experience disconnects in the delivery of care (e.g. inade-
quacies in treatment goal setting and time spent in visits).
This study sought to identify key factors in empowerment
and their association with patient characteristics. Two
important components of empowerment—positive patient–
provider interactions and knowledge and personal con-
trol—were identified. Levels of these empowerment factors
varied across disease type.
4.1 Descriptive Findings
Patients were actively involved in information seeking, and
generally reported satisfaction with access to and provision
of care, and high levels of prediagnosis involvement in
Table 2 Exploratory factor analysis and internal consistency of the empowerment itemsa
Items/questions Positive Patient–Provider Interaction
(Factor 1) (Cronbach’s a = 0.89)
Knowledge and Personal Control
(Factor 2) (Cronbach’s a = 0.79)
How satisfied are you with the relationship you have with the
healthcare provider who treats your primary condition?
0.88
Are you satisfied with the follow-up care you receive from the
healthcare provider who treats your primary condition?
0.87
How much trust do you have in the competence of the healthcare
provider who treats your primary condition?
0.82
To what extent do you feel your main healthcare provider monitors
your ongoing care?
0.73
How much do your treatment goals match with your healthcare
providers’ treatment plan?
0.71 0.47
How much of the health information you received from healthcare
providers during your visits was clear and easy to understand?
0.50 0.45
How much say do you think you have in making decisions about
your treatment?
0.49 0.44
How much of the information that you receive in the educational
materials during your visits is clear and easy to understand?
0.47 0.42
I am aware of the warning signs/symptoms related to my primary
health condition
0.74
I feel confident in managing any warning signs/symptoms of my
primary health condition
0.75
I am well-informed about the available treatment options for my
primary health condition
0.49 0.72
I know how my primary condition progresses over time 0.61
I have as much support as I need from friends to help care for and
manage my condition
0.48
Of the educational information you read about health, how much of
it is clear and easy to understand?b
0.40
I have as much family support I need to help care for and manage
my condition
0.44
Of the health information about test results and medical reports you
receive, how much of it is clear and easy to understand?
0.45 0.50
Bold numbers represent loadings of items 1–8 on Factor 1, and items 9–16 on Factor 2. Psychometric testing of factors demonstrated
acceptable Cronbach’s a for each subscale (a[ 0.79)
a EFA identified two components; principal axis factoring followed by promax rotation was run using the two-factor solution. Sixteen (n = 16)
items loaded[0.4
b Item 14 (in italics) was removed due to poor discriminant validity, as measured by corrected item-to-total correlation (correlations between
items and total domain score with the item excluded in the domain total; not shown in the table)
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medical decision making. It is not only provider relation-
ships that are important in empowerment. Many partici-
pants in this study report enabling other patients and
learning from others. Previous studies indicate that
empowered patients demonstrate sensitivity to other
patients and show a willingness to assist peers with similar
problems [10]. However, even in this generally empowered
group, there were concerns; sizable minorities of patients
reported mismatches in their treatment goals compared
with their providers’ plans, insufficient time spent with
providers during visits, and inadequate provider monitoring
of ongoing care. This highlights the provider role in
developing an empowering relationship in which the pro-
vider constructs a positive atmosphere by encouraging
Table 3 Mean empowerment scores (total and factor level) with 95 % CIs across sociodemographic strata
Positive Patient–Provider Interaction
Score [mean (95 % CI)]
Knowledge and Personal Control
Score [mean (95 % CI)]
Total Empowerment Score
[mean (95 % CI)]
Age categories, years
18–34 Gen Y 30.2 (29.4–30.9) 25.7 (25.1–26.2) 56.5 (55.3–57.7)
35–44 Gen X 30.2 (29.6–30.8) 25.6 (25.2–26.0) 56.7 (55.8–57.6)
45–54 young boomers 31.6 (31.2–32.0) 26.5 (26.2–26.8) 58.5 (57.9–59.2)
55–64 old boomers 32.3 (31.9–32.7) 27.1 (26.8–27.3) 59.9 (59.4–60.5)
65–74 silent generation 33.8 (33.3–34.2) 28.0 (27.7–28.4) 62.1 (61.3–62.8)
75–100 GI generation 33.5 (32.2–34.7) 27.8 (26.7–28.8) 61.9 (59.9–63.9)
Gender
Male 32.5 (32.1–32.9) 27.8 (27.5–28.1) 60.7 (60.1–61.3)
Female 31.6 (31.3–31.8) 26.4 (26.2–26.5) 58.5 (58.1–58.9)
Health insurance
Yes 32.1 (31.9–32.3) 26.9 (26.7–27.0) 59.5 (59.1–59.8)
No 28.2 (27.1–29.3) 24.9 (24.2–25.6) 54.3 (52.7–55.9)
Education
High school or less 30.8 (30.2–31.4) 26.2 (25.8–26.6) 57.9 (56.9–58.8)
College 31.9 (31.6–32.2) 26.6 (26.4–26.8) 59.0 (58.6–59.5)
Advanced education 32.7 (32.3–33.1) 27.7 (27.4–28.0) 60.7 (60.1–61.4)
Work status
Able to work 32.0 (31.7–32.3) 27.1 (26.9–27.3) 59.7 (59.3–60.1)
Medically unable to work 31.7 (31.3–32.0) 26.2 (25.9–26.5) 58.5 (57.9–59.0)
Primary condition
Fibromyalgia 29.7 (29.1–30.2) 24.8 (24.5–25.2) 55.3 (54.4–56.1)
Multiple sclerosis 33.1 (32.7–33.5) 27.8 (27.5–28.1) 60.3 (60.7–61.9)
Parkinson’s disease 33.5 (32.9–34.1) 28.0 (27.5–8.5) 61.8 (60.9–62.7)
Type 2 diabetes mellitus 32.6 (31.7–33.5) 27.4 (26.7–28.1) 60.8 (59.4–62.2)
Epilepsy 30.9 (29.8–32.0) 26.7 (26.0–27.5) 58.0 (56.3–59.7)
Bipolar disorder type 2 32.2 (30.5–33.8) 26.6 (25.3–27.9) 58.1 (55.4–60.9)
Rheumatoid arthritis 32.3 (31.1–33.5) 26.9 (26.1–27.7) 59.5 (57.7–61.3)
Amyotrophic lateral sclerosis 33.0 (31.7–34.3) 28.4 (27.7–29.1) 61.2 (59.2–63.1)
Systemic lupus erythematosus 29.4 (27.9–30.9) 25.6 (24.6–26.6) 55.7 (53.3–58.1)
Major depressive disorder 30.5 (28.9–31.6) 24.5 (23.6–25.5) 55.7 (53.8–57.5)
Idiopathic pulmonary fibrosis 33.0 (31.7–34.3) 28.0 (27.1–28.9) 61.1 (59.2–63.1)
Myalgic encephalomyelitis/
chronic fatigue syndrome
28.6 (26.5–30.7) 24.7 (23.4–26.0) 54.8 (51.7–58.0)
Migraine 30.8 (29.1–32.5) 25.8 (24.7–26.9) 57.3 (54.9–59.8)
Participants had the option of choosing not to respond to the survey questions. Scores are computed on all available data
Statistically significant difference (p\ 0.05) is noted if the 95 % CI between strata do not overlap. For example, the 95 % CI for the total
empowerment score ranges from 60.1 to 61.3 in males and from 58.1 to 58.9 in females. As the intervals do not overlap, the difference is
statistically significant
EFA exploratory factor analysis, CI confidence interval
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patients’ emotional expression, offering individualized
education, and allowing patients the time to make decisions
[8].
4.2 Empowerment Factors
The patient and provider roles in empowerment were
exemplified in the factors identified in this study—Positive
Patient–Provider Interaction and Knowledge and Personal
Control—which correspond to factors reported by Small
et al. [10], i.e. ‘knowledge and confidence in decision
making’ and ‘positive attitude and sense of control’. The
Positive Patient–Provider Interaction factor included items
related to patient satisfaction, comprehension, and active
involvement in treatment, and these have been associated
with patient empowerment in previous studies [25]. John-
son et al. [12] identified two empowerment factors in HIV-
infected patients—Informed, Committed, Collaborative,
Engaged (ICCE), and Tolerance of Uncertainty (TU). The
former subscale includes items associated with gaining
knowledge and interacting with providers. Although the
causality path is not clear from these data, it seems evident
that empowerment includes a sense of self-efficacy in
health information seeking, and a positive communication
style between patients and providers [8].
The analysis of these empowerment factors yielded
several key findings related to individual characteristics.
Patients who are male, more educated, and insured evi-
denced greater levels of empowerment. Previous studies
have found that men evidence higher empowerment levels
than women [26]. A study of empowerment in diabetes
patients also found a significant effect of gender where
female patients may be struggling with greater psycho-
logical or family communication problems than males [27].
We also found that with increasing age, empowerment
scores increased on both factors. Perhaps factors such as
being male, older, and employed confer greater financial

























































Diﬀerence from weighted sample mean of 26.7
Knowledge and Personal Control
Fig. 2 Analysis of means with
Nelson–Hsu adjustment analysis
of empowerment scores by
primary condition. Numbers
indicate difference from the
overall weighted sample mean.
Statistical significance after
Nelson–Hsu adjustment is
denoted by an asterisk
(***p\ 0.001, **p\ 0.01,
*p\ 0.05)
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Patients with myalgic encephalomyelitis/chronic fatigue
syndrome and fibromyalgia scored lower on both factors
compared with patients with amyotrophic lateral sclerosis,
Parkinson’s disease, and multiple sclerosis. The analysis of
individual scale items in the Positive Patient–Provider
Interaction factor indicated that the former groups of
patients may feel less informed by their providers. With
fibromyalgia and chronic fatigue syndrome, educational
and self-management interventions that may enhance
empowerment have been underutilized due to limited
medical understanding, difficulties accessing qualified
therapists, and lack of insurance coverage [28]. In addition,
fibromyalgia and chronic fatigue syndrome may carry a
stigma that detracts from empowerment as many of these
patients perceive distrust and skepticism by their physi-
cians with regard to their symptoms and clinical presen-
tation [29]. Patients may face similar barriers in other
stigmatized diseases such as mental health conditions [30],
hepatitis C [31], and HIV [32]. The presence of stigma may
lead to coping strategies that prevent empowerment, e.g.
withdrawing from health providers or concealing infor-
mation [33].
4.3 Limitations
There are several limitations worth noting. First, the EFA
did not establish the factors within empowerment in a
definitive manner. The purpose of this study was not to
examine the dimensionality and psychometric properties of
the items; hence, the EFA was purely exploratory. It is
possible that some items that measure the constructs and
domains of empowerment may not have been identified.
Furthermore, given the cross-sectional design of the study,
cause, effect or mediating pathways between the factors
and improved patient outcomes could not be established.
Additionally, because PLM is a real-world dataset, it pos-
sesses the limitations associated with such data, including
self-selection and recall bias. It may represent the patient
voice but the data are based on subjective self-reports, are
derived from a convenience sample, and the mix of patients
is representative of PLM and not necessarily of the medical
population at large. No independent assessment of partic-
ipants’ health status was carried out. Finally, the PLM
population skews toward a more educated, female popu-
lation with chronic conditions, although this is typical for
many health-oriented websites [34, 35]. In addition, this
sample underrepresents the prevalent primary chronic dis-
eases such as cardiometabolic diseases, so-called ‘silent’
diseases that may not lead people to join online social
networks. One might reasonably expect that the issues
highlighted in this paper may be more amplified in those
with less financial resources, inadequate computer access,
or limited knowledge of healthcare. However, this study
may be more representative of chronic disease patients who
are attuned to health issues or may be more engaged in
their healthcare, an important subgroup that may help
identify the issues that apply to the broader chronic disease
population. Future surveys may benefit from strategies
suggested by Dillman et al. [16], including email prompt-
ing, mixed methods (adding mail surveys), and the use of
financial incentives to draw a broader chronic disease
sample.
4.4 Future Work
Ultimately, such analyses may inform actionable steps that
both providers and researchers can take in order to
understand and improve patient empowerment. In terms of
actionable steps for providers, several possibilities emerge
from this data: (i) greater attention to achieving consensus
with patients regarding treatment goal setting; (ii) provi-
sion of sufficient time to discuss patients’ treatment needs
during visits; (iii) promoting patients’ health literacy to
ensure that their informational needs have been met; and
(iv) enhancing patients’ sense of control in managing their
disease through an understanding of disease warning signs/
symptoms, disease progression, and available treatment
options. With certain groups, such as women and those
with lesser education and health benefits, the provision of
such strategies in an empowering atmosphere may be
particularly critical.
Conditions that are difficult to diagnose and treat, or
those that are stigmatized, may be linked to problematic
interactions between provider and patient, and potentially
associated with lower levels of empowerment. In diseases
such as fibromyalgia, the psychosocial aspects of medical
management become more essential, which may be due in
part to providers’ lack of training and knowledge in
effective therapies that address these challenges [36].
Indeed, these patients expect more moral support from
health professionals, while providers often need to address
sources of frustration in treating difficult patients [37]. The
use of advocacy and support groups may help bridge this
gap. The creative use of evidence-based peer education
programs can help advocates to engage and teach rudi-
mentary empowerment skills to less empowered patients.
The involvement of providers is important, especially in
encouraging newly diagnosed patients to make contact and
speak with advocacy groups.
In terms of future research, interpersonal and intraper-
sonal factors in empowerment have been identified but the
causal relationships remain unclear [8]. Johnson postulates
the role of personal resources, cultural/social/environmen-
tal factors, and intrapersonal factors as drivers of patient
empowerment [9]. Further investigation of the most
important outcome(s) is warranted. If empowerment can be
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considered an outcome, we envision further work to define
it—as a set of positive health behaviors (e.g. self-man-
agement), enhanced clinical outcomes, or improved quality
of life [8]. In addition, once an outcome is defined, it will
be important to test the hypothesized multifactorial and
mediating pathways of empowerment using causal models
such as path analysis and structural equation modeling.
Finally, research should address not only the types and
severity of conditions but also differential disease charac-
teristics that affect patient empowerment.
5 Conclusions
The goal of the present study was to gain an understanding
of empowerment in terms of patient involvement with
health information seeking, provider and peer interactions,
and the access of healthcare. Even a fairly health-engaged
chronic disease population can experience difficulties with
aligning their goals with provider treatment goals and
spending sufficient time with providers. This study identi-
fied two domains of empowerment that are consistent with
previous studies. Empowerment levels differ across dis-
eases, particularly those that are difficult to diagnose and
treat, suggesting tailored disease-specific strategies to
empower patients. Future work should address ways in
which providers can overcome problematic interactions
with patients, and research that can better define the rela-
tionship between empowerment domains and important
clinical outcomes.
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